JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CYTH
6551
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $213 | ﹤0.01% |
153
+135
| +750% | +$223 |
2023 Q3
2 quarters
|
|
6552
Idaho Strategic Resources
IDR
$437M
| $212 | ﹤0.01% |
25
-73
| -74% | -$518 |
2023 Q3
2 quarters
|
|
|
CNTB
6553
Connect Biopharma Holdings
CNTB
$58.5M
| $211 | ﹤0.01% |
121
| – | – |
2021 Q4
9 quarters
|
|
6554
Quantum Corp
QMCO
$1.37B
| $210 | ﹤0.01% |
18
+3
| +20% | +$27 |
2020 Q1
16 quarters
|
|
6555
Alpha Teknova
TKNO
$478M
| $210 | ﹤0.01% |
83
| – | – |
2021 Q3
10 quarters
|
|
6556
iShares Global Financials ETF
IXG
$691M
| $209 | ﹤0.01% |
2
| – | – |
2018 Q4
21 quarters
|
|
|
SSKN
6557
DELISTED
Strata Skin Sciences
SSKN
| $208 | ﹤0.01% |
55
-8
| -13% | -$42 |
2023 Q3
2 quarters
|
|
6558
Research Solutions
RSSS
$72.3M
| $205 | ﹤0.01% |
65
-52
| -44% | -$149 |
2022 Q3
6 quarters
|
|
6559
Aptevo Therapeutics
APVO
$3.2M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
|
TBNK
6560
DELISTED
Territorial Bancorp Inc.
TBNK
| $202 | ﹤0.01% |
25
-2,060
| -99% | -$19.8K |
2014 Q1
40 quarters
|
|
6561
Banco de Chile
BCH
$19.6B
| $200 | ﹤0.01% |
9
-98,677
| -100% | -$2.22M |
2021 Q3
10 quarters
|
|
6562
T. Rowe Price Equity Income ETF
TEQI
$473M
| $200 | ﹤0.01% |
4
| – | – |
2022 Q4
5 quarters
|
|
|
AC
6563
DELISTED
Associated Capital Group
AC
| $196 | ﹤0.01% |
6
| – | – |
2023 Q3
2 quarters
|
|
6564
Rigetti Computing
RGTI
$4.97B
| $186 | ﹤0.01% |
122
-1,535
| -93% | -$2.22K |
2022 Q2
7 quarters
|
|
6565
Frequency Electronics
FEIM
$949M
| $185 | ﹤0.01% |
17
-18
| -51% | -$190 |
2023 Q3
2 quarters
|
|
|
ZFOX
6566
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $185 | ﹤0.01% |
165
+62
| +60% | +$61 |
2023 Q3
2 quarters
|
|
6567
Canterbury Park Holding Corp
CPHC
$81.4M
| $181 | ﹤0.01% |
8
+1
| +14% | +$23 |
2023 Q3
2 quarters
|
|
|
CNSY
6568
Cerenome
CNSY
$11.7M
| $181 | ﹤0.01% |
4
| – | – |
2023 Q3
2 quarters
|
|
|
GGZ
6569
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$117M
| $180 | ﹤0.01% |
15
-2,361
| -99% | -$27.4K |
2023 Q4
1 quarter
|
|
6570
Direxion Daily Retail Bull 3X ETF
RETL
$26.8M
| $180 | ﹤0.01% |
+16
| New | +$146 |
2024 Q1
0 quarters
|
|
|
FARM
6571
DELISTED
Farmer Brothers
FARM
| $179 | ﹤0.01% |
50
-53
| -51% | -$184 |
2013 Q2
43 quarters
|
|
|
EPIX
6572
DELISTED
ESSA Pharma
EPIX
| $178 | ﹤0.01% |
21
| – | – |
2020 Q3
14 quarters
|
|
|
SUP
6573
DELISTED
Superior Industries International
SUP
| $177 | ﹤0.01% |
61
-165
| -73% | -$522 |
2023 Q3
2 quarters
|
|
6574
Team
TISI
$132M
| $173 | ﹤0.01% |
24
+2
| +9% | +$13 |
2013 Q2
43 quarters
|
|
|
ACHL
6575
DELISTED
Achilles Therapeutics
ACHL
| $171 | ﹤0.01% |
137
-852
| -86% | -$919 |
2021 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.